// App-Quantinova.ai

BSH2020‐EP‐084 : ACOPP chemotherapy for front‐line treatment of older patients with Hodgkin lymphoma – a pilot study

Researchers

Presenter

  • M. Wilson

Principal Investigators

  • P. McKay

  • K. Parsons

  • C. Ogilvie

  • J. Travers

  • M. Martin

  • J. Allan

  • W. Osborne

  • M. Leach

Medical Centers

  • Beatson West of Scotland Cancer Centre, GLASGOW

  • Newcastle Upon Tyne Hospitals NHS Trust, Newcastle

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Peripheral Nervous System

  • Gastroenterology (GU)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Hodgkin's Lymphoma

  • Peripheral neuropathy

  • Diabetic neuropathy

  • Orthostatic hypotension

  • Thrombocytopenia

  • Constipation

  • Neutropenia

  • Lymphomas

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • procarbazine

  • Prednisolone

  • Adcetris

  • Vincristine

  • Doxorubicin

  • Etoposide

  • Etoposide phosphate

  • Bleomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved